Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CytomX Therapeutics (CTMX) Current Taxes: 2017-2019

Historic Current Taxes for CytomX Therapeutics (CTMX) over the last 1 years, with Mar 2019 value amounting to $13.4 million.

  • CytomX Therapeutics' Current Taxes rose 1192.17% to $13.4 million in Q1 2019 from the same period last year, while for Mar 2019 it was $13.4 million, marking a year-over-year increase of 1192.17%. This contributed to the annual value of $13.3 million for FY2018, which is 1333800.00% up from last year.
  • As of Q1 2019, CytomX Therapeutics' Current Taxes stood at $13.4 million, which was up 0.26% from $13.3 million recorded in Q4 2018.
  • In the past 5 years, CytomX Therapeutics' Current Taxes registered a high of $13.4 million during Q1 2019, and its lowest value of $1,000 during Q4 2017.
  • In the last 3 years, CytomX Therapeutics' Current Taxes had a median value of $3.8 million in 2018 and averaged $5.9 million.
  • Data for CytomX Therapeutics' Current Taxes shows a peak YoY skyrocketed of 1,333,800.00% (in 2018) over the last 5 years.
  • CytomX Therapeutics' Current Taxes (Quarterly) stood at $1,000 in 2017, then spiked by 1,333,800.00% to $13.3 million in 2018, then spiked by 1,192.17% to $13.4 million in 2019.
  • Its Current Taxes was $13.4 million in Q1 2019, compared to $13.3 million in Q4 2018 and $5.0 million in Q3 2018.